FdaApplication

NDA 217604

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAMNEAL PHARMACEUTICALS LLC
application_typeNDA
approval_date2024-10-04

Products (1)

ProductActive ingredientStrengthDosage form
PYRIDOSTIGMINE BROMIDEPYRIDOSTIGMINE BROMIDE105MGTABLET, EXTENDED RELEASE;ORAL

1 product